Grandfield & Dodd’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-37,190
Closed -$2.98M 188
2016
Q4
$2.98M Sell
37,190
-2,175
-6% -$173K 0.39% 60
2016
Q3
$3.14M Sell
39,365
-4,900
-11% -$396K 0.41% 59
2016
Q2
$3.45M Buy
44,265
+8,035
+22% +$573K 0.48% 54
2016
Q1
$1.99M Buy
36,230
+15,280
+73% +$833K 0.29% 64
2015
Q4
$1.29M Buy
20,950
+5,608
+37% +$354K 0.2% 73
2015
Q3
$968K Buy
15,342
+870
+6% +$62.1K 0.16% 80
2015
Q2
$1.06M Buy
14,472
+5,667
+64% +$409K 0.16% 85
2015
Q1
$576K Buy
8,805
+3,855
+78% +$256K 0.09% 101
2014
Q4
$322K Hold
4,950
0.05% 135
2014
Q3
$298K Buy
4,950
+150
+3% +$9.8K 0.05% 136
2014
Q2
$332K Hold
4,800
0.05% 143
2014
Q1
$314K Sell
4,800
-165
-3% -$10.7K 0.05% 144
2013
Q4
$308K Buy
4,965
+700
+16% +$40.5K 0.05% 141
2013
Q3
$229K Buy
+4,265
New +$220K 0.04% 154

Other funds holding STJ

Grandfield & Dodd's STJ Position: Q1 2017 in Review

Grandfield & Dodd sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 37,190 shares — an estimated $2.98M sold.

Grandfield & Dodd first reported a position in STJ in Q3 2013 and held it in 14 quarters. The position peaked at $3.45M in Q2 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Grandfield & Dodd reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Grandfield & Dodd sold 37,190 St Jude Medical shares in Q1 2017, an estimated $2.98M.
  • Grandfield & Dodd first reported a position in St Jude Medical in Q3 2013 and held it in 14 quarters.
  • Grandfield & Dodd's St Jude Medical position peaked at $3.45M in Q2 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Grandfield & Dodd's 13F filing for Q1 2017, filed 28 Apr 2017.